banner add

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

from NYT > Health https://ift.tt/j4Eae0u
via IFTTT

No comments

Congo Ebola Crisis: Contact Tracing Is Dangerously Behind, Officials Warn

Most of the people testing positive for Ebola in the Democratic Republic of Congo are not on health workers’ radar, suggesting that contact ...

Theme images by PLAINVIEW. Powered by Blogger.